Protalix BioTherapeutics ... (PLX)
2.30
-0.03 (-1.29%)
At close: Mar 03, 2025, 3:59 PM
2.31
0.43%
After-hours: Mar 03, 2025, 08:00 PM EST
Protalix BioTherapeutics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 |
| Net Income | 8.31M | -14.93M | -27.58M | -6.52M | -18.28M | -26.46M | -85.28M | -29.18M | -27.28M | -29.94M | -27.79M | -11.62M | -36.53M | -29M | -31.44M | -22.41M | -22.48M | -9.39M | -74.93K | -160.07K | -140.71K | -149.76K | -329.17K | -105.61K | -997.87K | -1.15M | 118.44K | 131.68K |
| Depreciation & Amortization | 1.19M | 1.09M | 1.12M | 1.3M | 1.62M | 1.67M | 1.92M | 1.98M | 2.37M | 3.14M | 3.54M | 3.69M | 3.63M | 3.13M | 1.99M | 1.3M | 759K | 502K | n/a | n/a | n/a | n/a | n/a | n/a | 163.2K | 202.21K | n/a | n/a |
| Stock-Based Compensation | 3.45M | 2.08M | 2.38M | 3.13M | 835K | 514K | 337K | 988K | 1.8M | 1.24M | 4.09M | 7.75M | 886K | 1.28M | 2.68M | 3.07M | 10.85M | 3.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | -13.16M | -7.17M | 13.23M | -26.2M | -9.58M | 17.88M | 26.76M | -411K | 362K | -7.17M | -7.16M | 1.28M | -3M | -4.56M | 64.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.23K | 79.96K |
| Other Non-Cash Items | -638K | -1.23M | 3.09M | 3.64M | 3.37M | 3.07M | 4.57M | 581K | 569K | 1.89M | -137K | -171K | -36.37M | 377K | 265K | 3.05M | 11.1M | 3.57M | n/a | n/a | 4.25K | -150 | -66.29K | -141.3K | 508.36K | -526.47K | -343.84K | -243.74K |
| Deferred Income Tax | -3.09M | n/a | 813K | -522K | -68K | -64K | 39.35M | -7.59M | 1.56M | 115K | 142K | 240K | 36.87M | -617K | -218K | -3.03M | -11.71M | -3.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -32.75K | -8.47K |
| Change in Working Capital | -10.54M | -12.02M | 9.9M | -27.13M | -6.83M | 13.53M | 29.1M | 1.12M | -3.3M | -5.72M | -10.5M | 741K | 7.94M | -13.64M | 71.17M | 2.01M | 1.04M | 269K | 2.46K | -8.05K | -218 | 3.33K | -393.96K | 193.8K | -1.08M | 561.54K | 10.23K | 79.96K |
| Operating Cash Flow | -1.32M | -25M | -10.29M | -26.11M | -19.36M | -7.74M | -9.99M | -32.1M | -24.28M | -29.28M | -30.65M | 635K | -23.57M | -38.46M | 44.45M | -16.02M | -10.45M | -5.09M | -72.47K | -168.13K | -136.68K | -146.59K | -789.43K | -53.11K | -1.41M | -909.52K | -247.92K | -40.57K |
| Capital Expenditures | -1.15M | -628K | -1.46M | -655K | -627K | -686K | -971K | -849K | -464K | -785K | -1.89M | -2.07M | -5.71M | -7.86M | -6.2M | -3.37M | -2.33M | -842K | n/a | n/a | n/a | n/a | n/a | n/a | -29.3K | -139.99K | n/a | n/a |
| Acquisitions | n/a | n/a | 53K | n/a | n/a | n/a | 3K | 20K | 3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | -16M | -37.84M | -20M | n/a | n/a | n/a | n/a | n/a | -90K | -212K | -218K | -165K | -137K | n/a | n/a | n/a | -47K | n/a | n/a | -552.36K | n/a | n/a | -2.4M | -1.06M | -59.39K | n/a | -6.32M |
| Sales Maturities Of Investments | n/a | 11M | 57.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.22M | 2.24M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -15.56M | 593K | 327K | 703K | -256K | 95K | -148K | -118K | 39.85M | -126K | -212K | -218K | 2K | -137K | 21K | -330K | -103K | -91K | n/a | 552.36K | 60.88K | 38.59K | 97.11K | 226.88K | 1.62M | -3.65M | 31.89K | n/a |
| Investing Cash Flow | -16.71M | -5.04M | 18.92M | -19.95M | -883K | -591K | -1.12M | -967K | 39.39M | -1M | -2.1M | -2.29M | -5.87M | -7.99M | -6.17M | -3.7M | -2.44M | -980K | n/a | 552.36K | -491.48K | 38.59K | 1.31M | 71.37K | 532.43K | -3.85M | 31.89K | -6.32M |
| Debt Repayment | n/a | n/a | -34.12M | -215K | n/a | -4.75M | -1.42M | 19.68M | n/a | n/a | 66.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1M | 755K | n/a | n/a | n/a | -35K | -6.3K | -517.03K | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -56K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 1.42M | 2K | 46.2M | 472K | n/a | n/a | n/a | 14K | 534K | 46K | 112K | 1.23M | 277K | 501K | 293K | 5K | -104K | 341K | -6.88M | n/a | n/a | n/a | n/a | n/a | n/a | 6.48M | n/a | n/a |
| Financial Cash Flow | 24.67M | 8.24M | 12.08M | 46.47M | n/a | -4.75M | -1.42M | 19.7M | 6.63M | 46K | 66.89M | 26.56M | 20.93M | 501K | 293K | -51K | 58.57M | 16.71M | 494K | n/a | n/a | n/a | n/a | -35K | -6.3K | 5.97M | n/a | 7.05M |
| Net Cash Flow | 6.52M | -21.87M | 20.72M | 473K | -20.02M | -13.36M | -12.12M | -13.09M | 21.61M | -31.63M | 34.36M | 25.03M | -8.9M | -45.37M | 38.67M | -19.22M | 46.44M | 10.64M | 421.52K | 384.23K | -628.16K | -108K | 524.9K | -16.73K | -882.01K | 1.2M | -216.03K | 687.89K |
| Free Cash Flow | -2.47M | -25.63M | -11.74M | -26.76M | -19.98M | -8.43M | -10.96M | -32.95M | -24.75M | -30.07M | -32.54M | -1.43M | -29.27M | -46.32M | 38.26M | -19.39M | -12.78M | -5.93M | -72.47K | -168.13K | -136.68K | -146.59K | -789.43K | -53.11K | -1.44M | -1.05M | -247.92K | -40.57K |